RNST - CIK 0000715072
The table below shows RENASANT CORP's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.07B | $1.09B | $801.35M | $575.99M | $1.88B | $633.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | $283.60M | $293.12M | $300.50M |
| Goodwill | $1.41B | $988.90M | $991.66M | $991.71M | $939.68M | $939.68M |
| Total assets | $26.75B | $18.03B | $17.36B | $16.99B | $16.81B | $14.93B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | $499.76M | $430.61M | $429.40M | $428.13M | $471.21M | $474.97M |
| Total liabilities | $22.87B | $15.36B | $15.06B | $14.85B | $14.60B | $12.80B |
| Retained earnings | $1.20B | $1.09B | $952.12M | $857.73M | $741.65M | $615.77M |
| Total equity | $3.88B | $2.68B | $2.30B | $2.14B | $2.21B | $2.13B |